Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NL-OMON58526) titled 'ProPCI' on April 7.
Study Type: Observational
Study Design:
N/A: single arm study, Open (masking not used), Uncontrolled, single, Other
Primary Sponsor: Radboud Universitair Medisch Centrum
Condition:
High risk localized prostate cancer, synchronous metastatic hormone-sensitive prostate cancer Aggressive prostate cancer, metastatic prostate cancer
10038597
Intervention:
Not applicable.
Recruitment Status: Not Recruiting
Phase: NA
Date of First Enrollment: 2026-05-01
Target Sample Size: 700
Countries of Recruitment:
Netherlands
To know more, visit https://onderzoekmetmensen.nl/en/trial/58526
Discla...